Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
US7572882B2 · kind B2 · utility
4Cited by
27References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2000 |
| Grant date | Aug 11, 2009 |
| Priority date | — |
| Expiry date | Nov 2, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare human papillomavirus (HPV) epitopes, and to develop epitope-based vaccines directed towards HPV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HPV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.